A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections

BACKGROUND: At the present time, COVID-19 vaccines are at the testing stage, and an effective treatment for COVID-19 incorporating appropriate safety measures remains the most significant obstacle to be overcome. A strategic countermeasure is, therefore, urgently required. AIM: This study aims to ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Purwati, Budiono, Rachman, Brian Eka, Yulistiani, Miatmoko, Andang, Nasronudin, Lardo, Soroy, Purnama, Yongki Iswandi, Laely, Mafidhatul, Rochmad, Ike, Ismail, Taufik, Wulandari, Sri, Setyawan, Dwi, Rosyid, Alfian Nur, Setiawan, Herley Windo, Wulaningrum, Prastuti Asta, Asmarawati, Tri Pudy, Marfiani, Erika, Yuniati, Shinta Karina, Fuadi, Muhammad Rabiul, Endraswari, Pepy Dwi, Purwaningsih, Hendrianto, Eryk, Karsari, Deya, Dinaryanti, Aristika, Ertanti, Nora, Ihsan, Igo Syaiful, Purnama, Disca Sandyakala, Indrayani, Yuni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881739/
https://www.ncbi.nlm.nih.gov/pubmed/33628506
http://dx.doi.org/10.1155/2021/6685921

Ejemplares similares

Ejemplares similares